SEC Comment Letter for TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133) (TNDM) — May 8, 2018
TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133)
Date: May 8, 2018 · CIK: 0001438133 · Accession: 0000000000-18-014276
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 3030 May 8, 2018 Via E -mail Kim D. Blickenstaff President, Chief Executive Officer and Director Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego, California 92121
Re: Tandem Diabetes Care, Inc. Registration Statement on Form S-3 Filed April 26, 2018 File No. 333 -224460
Dear M r. Blickenstaff :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Show Raw Text
Mail Stop 3030
May 8, 2018
Via E -mail
Kim D. Blickenstaff
President, Chief Executive Officer and Director
Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego, California 92121
Re: Tandem Diabetes Care, Inc.
Registration Statement on Form S-3
Filed April 26, 2018
File No. 333 -224460
Dear M r. Blickenstaff :
This is to advise you that we have not reviewed and will not review your registration
statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tom Jones at (202) 551 -3602 with any questions.
Sincerely,
/s/ Tom Jones for
Amanda Ravitz
Assistant Director
Office of Electronics and Machinery
cc: David B. Berger, Esq.